D-dimer levels predict COVID-19 severity and mortality.
暂无分享,去创建一个
M. Jaguszewski | Błażej Nowak | J. Ładny | K. Filipiak | Ł. Szarpak | A. Gąsecka | K. Ruetzler | J. Smereka | Michal Pruc | N. Gilis-Malinowska | Michał Pruc | M. Pruc
[1] M. Jaguszewski,et al. Lactate dehydrogenase level as a COVID-19 severity marker , 2020, The American Journal of Emergency Medicine.
[2] L. Szarpak,et al. Can hematological and biochemical parameters fasten the diagnosis of COVID-19 in emergency departments? , 2020 .
[3] M. Lelonek,et al. The patient with heart failure in the face of the coronavirus disease 2019 pandemic: an expert opinion of the Heart Failure Working Group of the Polish Cardiac Society , 2020, Kardiologia Polska.
[4] B. Payrastre,et al. Thromboembolic events and Covid-19 , 2020, Advances in Biological Regulation.
[5] Mario Plebani,et al. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis , 2020, The American Journal of Emergency Medicine.
[6] J. Thachil,et al. SARS-2 Coronavirus–Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism? , 2020, Seminars in Thrombosis and Hemostasis.
[7] M. Makris,et al. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation , 2020, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[8] A. Torbicki,et al. Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative , 2019, Cardiology journal.